Medical & Pharma Meetings>Continuing Medical Education

Should pharmaceutical companies dictate business practices for continuing medical education providers?

Are pharmaceutical companies overstepping their boundaries by criticizing continuing medical education providers' business development practices?

Karen Overstreet, EdD, RPh, FACME, CCMEP, Jacqueline Parochka, EdD, FACME | Sep 01, 2008

The Case

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

TAGS: Medical & Pharma Meetings

Hide comments

Load More

Comments

Plain text